Manufacturer`s Suggested Retail Price $9.64 Use with extreme caution in hemodynamically unstable patients (Dyer 2011).• Maternal deaths: Maternal deaths caused by hypertensive episodes, subarachnoid hemorrhage, or rupture of the uterus and fetal deaths have occurred with oxytocic medications when used for induction of labor or for augmentation in the first and second stages of labor.• Uterine effects: High doses or hypersensitivity to oxytocin may cause uterine hypertonicity, spasm, tetanic contraction, or rupture of the uterus.• Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Gemeprost: May enhance the adverse/toxic effect of Oxytocin.Haloperidol: QT-prolonging Agents (Indeterminate Risk - Caution) may enhance the QTc-prolonging effect of Haloperidol. The review included 2 randomized trials and 4 non-randomized controlled trials comparing oral misoprostol vs. placebo or no treatment for women during the third stage of labor.
Manufacturer`s Suggested Retail Price $4.26 Consult drug interactions database for more detailed information.• Appropriate use: Abortion: For the adjunctive management of abortion in the first trimester, curettage is generally considered primary therapy. Elective induction for convenience Cephalopelvic disproportion Unfavorable fetal position or presentation Uterine or cervical scarring Fetal distress when delivery is not imminent Placenta previa Prolapsed cord Multiparity Prolonged use with eclampsia. Manufacturer`s Suggested Retail Price $1.00
Slow IV injections (5 or 10 units over 1 minute) are preferred for women without cardiovascular risk factors; very slow injections (≥5 minutes) are preferred for women with cardiovascular risk factors (Sentilhes 2016).Carboprost Tromethamine: May enhance the adverse/toxic effect of Oxytocic Agents. Infusion rates up to 6 milliunits/minute provide oxytocin levels similar to those with spontaneous labor; rates >9 to 10 milliunits/minute are rarely required.Low-dose regimen (off-label dose): Initial 0.5 to 2 milliunits/minute, incrementally increase by 1 to 2 milliunits/minute every 15 to 40 minutes (ACOG 2009).High-dose regimen (off-label dose): Initial 6 milliunits/minute, incrementally increase by 3 to 6 milliunits/minute every 15 to 40 minutes. Socialist men under red father 3 follicles on clomid medscape propranolol early pregnancy cardizem gtt evista serm drug brand ivermectin prednisone 1000 mg iv reciprocity treaty of 1875 birth name generic cymbalta recall kamagra daily oral gel 100mg lamisil once cvs reciprocal inhibition research h reflex 1998 vigora red misoprostol postpartum hemorrhage acog para kamagra oral jelly koriscenje que es la …
Maximum cumulative dose: 40 units (Sentilhes 2016).The dose may be administered using a standardized infusion containing 30 units in 500 mL NS or LR (AWHONN 2015; Sumikura 2016) or by adding 10 to 40 units to a running infusion solution depending on amount of infusion fluid remaining (maximum: 40 units in 1,000 mL of IV fluid); adjust infusion rate to sustain uterine contraction and control uterine atony.Lower bolus doses (0.5 to 3 units) for the prevention of postpartum bleeding have also been evaluated in women undergoing elective cesarean delivery (Butwick 2010; Carvalho 2004).Incomplete, inevitable, or elective abortion: 10 units as an IV infusion after suction or a sharp curettage (used to help contract the uterus)Induction or stimulation of labor: Add oxytocin 10 units to NS or LR 1,000 mL to yield a solution containing oxytocin 10 milliunits/mL or 30 units in 500 mL NS or LR (AWHONN 2015).